Full history for every metric is available with a Kvantra account
ifa systems AG (IS8.DE)
Key financial summary
Financials in EUR| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 9 | 7 | 10 | 7 | 8 | 9 | 9 |
| Operating profit | €m | 3 | 3 | |||||
| Net profit | €m | -9 | 1 | 1 | 0 | 0 | 0 | 0 |
| EPS reported | € | 0.16 | 0.16 | |||||
| Operating cashflow per share | € | 0.00 | 0.00 | |||||
| Capex per share | € | 0.00 | 0.00 | |||||
| FCF per share | € | 0.00 | 0.00 | |||||
| Free cash flow | €m | 0 | 0 | |||||
| Net debt | €m | -1 | -1 | |||||
| Book value equity | €m | 9 | 9 | |||||
| Book value per share | € | 3.42 | 3.42 | |||||
| Number of shares | m | 2.75 | 2.75 | |||||
| DPS (TTM paid) | € | 0.00 | 0.00 |
Financial summary
Financials in EUR| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 24.12 | - | |||||
| P/B LTM | x | 1.13 | 0.77 | |||||
| P/S LTM | x | 1.23 | 0.84 | |||||
| P/FCF LTM | x | 0.00 | 0.00 | |||||
| EV/EBITDA LTM | x | 24.21 | 15.37 | |||||
| EV/Sales LTM | x | 1.15 | 0.73 | |||||
| Earnings Yield LTM | % | 4.15% | 6.17% | |||||
| FCF Yield | % | 0.00% | 0.00% | |||||
| Quality | ||||||||
| ROE | % | 4.76% | 4.86% | |||||
| ROIC | % | 17.13% | 17.13% | |||||
| Operating margin | % | 38.06% | 38.06% | |||||
| Gross margin | % | 30.08% | 30.08% | |||||
| FCF/Sales | % | 0.00% | 0.00% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | +2809.1% | +2809.1% | |||||
| Sales Growth YoY | % | +5.68% | +5.68% | |||||
| Net Income Growth YoY | % | +2886.7% | +2886.7% | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | +698.55% | +698.55% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.00 | 0.00 | |||||
| Net Debt/EBITDA | x | -1.56 | -1.56 | |||||
| EBIT/Net interest | x | 299.82 | 299.82 | |||||
| Net debt/market cap | % | -8.74% | -12.78% | |||||
| Net debt/Equity | x | -0.10 | -0.10 | |||||
| Gross debt/equity | x | 0.02 | 0.02 | |||||
Company overview
ifa systems AG is a global health IT company that develops, markets, and installs specialized software solutions and components for ophthalmologists and eye clinics. A core offering is its Electronic Medical Record (EMR) system, exclusively designed for ophthalmology, which enables thorough documentation and administration of examination results and treatments. This EMR can be seamlessly implemented in specialist practices, eye centers, and hospital ophthalmology departments. The company's product suite also includes a medical device interface system for aggregating and merging diverse ophthalmic data from various sources, and a clinical decision support system that analyzes patient data to provide insights on guidelines, treatment modalities, and risks. An integrated software connection platform facilitates the integration and interoperability of different software products, while its workflow management software streamlines treatment processes. Additionally, ifa systems offers web-based registry solutions specifically for cataract and refractive surgery treatments. Founded in 1987, the company is headquartered in Frechen, Germany, and operates as a subsidiary of Topcon Europe B.V.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
ifa systems AG (IS8.DE)
ifa systems AG is a global health IT company that develops, markets, and installs specialized software solutions and components for ophthalmologists and eye clinics. A core offering is its Electronic Medical Record (EMR) system, exclusively designed for ophthalmology, which enables thorough documentation and administration of examination results and treatments. This EMR can be seamlessly implemented in specialist practices, eye centers, and hospital ophthalmology departments. The company's product suite also includes a medical device interface system for aggregating and merging diverse ophthalmic data from various sources, and a clinical decision support system that analyzes patient data to provide insights on guidelines, treatment modalities, and risks. An integrated software connection platform facilitates the integration and interoperability of different software products, while its workflow management software streamlines treatment processes. Additionally, ifa systems offers web-based registry solutions specifically for cataract and refractive surgery treatments. Founded in 1987, the company is headquartered in Frechen, Germany, and operates as a subsidiary of Topcon Europe B.V.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free